6-(3-OXO-3,4-DIHYDROQUINOXALIN-2-YL)-3-CYANO-4,7-DIHYDROPYRAZOLO-[1,5-A]-PYRIMIDIN-7-ONE
Compound with spectra: 1 NMR
![6-(3-OXO-3,4-DIHYDROQUINOXALIN-2-YL)-3-CYANO-4,7-DIHYDROPYRAZOLO-[1,5-A]-PYRIMIDIN-7-ONE](/api/compound/LBeoXb6htU6.png?ph=true&h=300&w=458 "6-(3-OXO-3,4-DIHYDROQUINOXALIN-2-YL)-3-CYANO-4,7-DIHYDROPYRAZOLO-[1,5-A]-PYRIMIDIN-7-ONE")
| SpectraBase Compound ID | LBeoXb6htU6 |
|---|---|
| InChI | InChI=1S/C15H8N6O2/c16-5-8-6-18-21-13(8)17-7-9(15(21)23)12-14(22)20-11-4-2-1-3-10(11)19-12/h1-4,6-7,17H,(H,20,22) |
| InChIKey | OMUYTKNOPJOYII-UHFFFAOYSA-N |
| Mol Weight | 304.27 g/mol |
| Molecular Formula | C15H8N6O2 |
| Exact Mass | 304.070874 g/mol |
| Copyright | Copyright © 2016-2025 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | DMSO-D6 |
N-Cyclohexyl-2-cyclopropyl-2-(2-oxo-3-phenylquinoxalin-1-yl)acetamide
4-[ .alpha.-(3'-Methyl-5'-oxo-1'-phenyl-2'-pyrazolin-4'-yl)benzyl]-1,2,5,6-dihydro-(1,5)-benzodiazepin-2-one
5-EXO-TOSYLOXY-2,3-TETRAFLUOROBENZOBICYCLO[2.2.2]OCTADIENE
5-ENDO-TOSYLOXY-2,3-TETRAFLUOROBENZOBICYCLO[2.2.2]OCTADIENE
11-ALPHA-HYDROXY-3-OXO-4-BETA-H,5-ALPHA-H,6-ALPHA-H,7-ALPHA-H,10-BETA-METHYL-EUDESMAN-1,2-EN-6,12-OLIDE
Ethyl methyl 1,4-dihydro-2,6-dimethyl-4-(2'-phenyl-4H-[1']benzopyran-4'-oxo-6'-yl)-3,5-pyridinedicarboxylate
2-Cyclopropyl-2-(2-oxo-3-phenylquinoxalin-1(2H)-yl)-N-pentylacetamide
Iron, (benzenesulfonato-o)[5,10,15,20-tetrakis(4-methylphenyl)-21H,23H-porphinato(2-)-N21,N22,N23,N24]-, (sp-5-12)-
2-Acetyl-1,9-dimethylpyrazolo[1,5-c]quinazolin-5(6H)-one
9-CYANO-2-TRIFLUOROMETHYL-11-TRIMETHYLSILYL-6H-INDOLO-[2,3-B]-QUINOLINE
| Title | Journal or Book | Year |
|---|---|---|
| Synthesis of 6-quinoxalinyldihydropyrazolo[1,5-a]pyrimidin-7-ones by a ring transformation. Tautomeric structure of dihydropyrazolo[1,5-a]pyrimidin-7-ones in a solution | Journal of Heterocyclic Chemistry | 1990 |